改善卵母细胞体外成熟结局的研究进展  

Research progress on improving the maturation outcome of oocytes in vitro

作　　者：包云 柴娟[1] 卢俏俏 师帅[1] 郑群[1] 邹立波[1] Bao Yun;Chai Juan;Lu Qiaoqiao;Shi Shuai;Zheng Qun;Zou Libo(Center of Reproductive Medicine,Jinhua People’s Hospital,Jinhua,Zhejiang 321000,China)

机构地区：[1]金华市人民医院生殖中心,浙江金华321000

出　　处：《医药前沿》2020年第18期10-11,共2页Journal of Frontiers of Medicine

基　　金：金华市科学技术研究计划项目(2019-4-030);金华市科学技术研究计划项目(2019-4-036)。

摘　　要：卵母细胞体外成熟技术作为一种有效的治疗手段,目前应用于多囊卵巢综合征,卵巢高反应或低反应患者,卵巢早衰,肿瘤患者生育能力保存等。然而,该技术应用中存在卵母细胞成熟率偏低,胚胎发育潜能差的问题。本文就目前国内外在改善卵母细胞体外成熟结局的研究进展作简要综述。In vitro maturation of oocytes as an effective treatment is currently used in polycystic ovary syndrome,patients with high or low ovarian response,premature ovarian failure,and preservation of fertility in tumor patients.However,the application of this technology has the problems of low oocyte maturation rate and poor embryonic development potential.This article briefly reviews the current research progress in improving the maturation of oocytes in vitro and abroad.

关 键 词：体外成熟 颗粒细胞 生殖激素 抗氧化剂 能量物质 

分 类 号：R711.6[医药卫生—妇产科学]